FBLN5
protein-codingfibulin 5, the group of Fibulins
Gene summary
The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~78.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013751
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0019572
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0019571
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009052
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0018776
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0013751
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009052
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0017237
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0018776
Submitter: ClinGen
FBLN5 was first reported in relation to autosomal dominant demyelinating hereditary motor and sensory neuropathy in 2011 (PMID: 21576112). FBLN5 is a member of the fibulin family of proteins which are extracellular matrix proteins characterized by tandem arrays of EGF-like domains and a C-terminal fibulin-type module. This gene consists of 11 exons that are differentially combined in three major transcripts. FBLN5 is also reported in association with autosomal dominant and recessive cutis laxa, a connective tissue disorder, and autosomal dominant age-related macular degeneration. Available data and input from our expert panel indicates these phenotypes should be split: there is phenotypic variability, differences in inheritance pattern (autosomal recessive, autosomal dominant, and autosomal dominant with age-related penetrance), and differences in molecular mechanism (cutis laxa variants are biallelic loss of function or heterozygous dominant-negative, which is different from the variants associated with macular degeneration and neuropathy). However, there are cases with overlapping features suggesting a possible phenotypic spectrum. For example, many of the individuals referenced in this curation have neuropathy with variable connective tissue features (hyperelastic skin, hypermobility) and age-related macular degeneration. There is at least one variant that has been reported in both individuals with neuropathy and in individuals with isolated age-related macular dystrophy (p.G267S, PMID: 21576112). In this curation, we scored evidence for 6 missense variants in over 15 families (some with shared haplotype)- p.G90S, p.V126M, p.G267S, p.D329V, p.R331H, and p.R373C (PMIDs: 21576112, 23328402, 28332470, 31945625, 32757322). A single variant (p.R373C) arose in multiple unique haplotypes and is considered a hotspot variant. Age of onset and phenotype varied between and within families but generally consisted of adult-onset progressive peripheral sensorimotor neuropathy with foot deformities, upper and lower limb sensory disturbances, and impaired gait with or without hypo/areflexia, muscle weakness, hyperelastic skin, hypermobility, and age-related macular degeneration. The mechanism of pathogenicity appears to be loss-of-function. Genetic evidence score totaled 3.1. Of note, there are additional families and variants not included in this curation as insufficient clinical data was reported (e.g. lack of electromyography to confirm neuropathy). A single publication reports extensive experimental evidence including expression data, non-patient cell functional alteration, non-human model organism, and rescue in a non-human model organism (PMID: 33107705). The non-human (zebrafish) model showed that lack of FBLN5 leads to myelination defects which can be rescued to normal myelination levels with exogenous overexpression of FBLN5. Experimental evidence score is 5. The total score is 8.1. In summary, FBLN5 is moderately associated with autosomal dominant demyelinating hereditary motor and sensory neuropathy. **Recuration Update**: No new literature evidence was found in 2026 so the classification remains unmodified.
Inheritance Pattern: AR
Disease ID:MONDO:0009052
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0012145
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0013751
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009052
Submitter: Genomics England PanelApp
Inheritance Pattern: SD
Disease ID:MONDO:0009052
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0030689
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Dermatologic; Cardiovascular; Gastrointestinal; Genitourinary; Neurologic; Ophthalmologic; Pulmonary
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FBLN5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006329.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 130 | 1 | 136 | ||
| missense | 1 | 8 | 283 | 8 | 1 | 301 |
| nonsense | 2 | 3 | 8 | 13 | ||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 4 | 11 | 302 | 138 | 2 | 457 |
Highest pathogenic variant AF is 0.000054527383
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006320.2 | 11 | MANE Select | |
| Ensembl | ENSP00000345008.4 | 11 | MANE Select | |
| RefSeq | NP_001371087.1 | 12 | Standard | |
| RefSeq | NP_001371088.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Extracellular matrix organization
- Molecules associated with elastic fibres
- Elastic fibre formation
Biological Process
- regulation of cell growth
- cell-matrix adhesion
- extracellular matrix organization
- protein localization to cell surface
- secretion
Molecular Function
- integrin binding
- calcium ion binding
- protein binding
- protein C-terminus binding
- extracellular matrix constituent conferring elasticity
Cellular Component
- extracellular region
- extracellular space
- extracellular matrix
- collagen-containing extracellular matrix
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000342058
- Coding exons
- 11
- Length
- 78576
- Individuals with no LoFs
- 125741
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 2
- Defined
- 125743
- p
- 0.00000795
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.56 | 199 | 271 | 0.734 | 0.0000175 | 2947 |
| Missense (PolyPhen) | 39 | 90.043 | 0.43313 | 1090 | ||
| Synonymous | 0.419 | 100 | 105 | 0.948 | 0.00000747 | 843 |
| Loss of Function | 4.70 | 1 | 27.6 | 0.0362 | 0.00000153 | 302 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000090 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Essential for elastic fiber formation, is involved in the assembly of continuous elastin (ELN) polymer and promotes the interaction of microfibrils and ELN (PubMed:18185537). Stabilizes and organizes elastic fibers in the skin, lung and vasculature (By similarity). Promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. Vascular ligand for integrin receptors which may play a role in vascular development and remodeling (PubMed:10428823). May act as an adapter that mediates the interaction between FBN1 and ELN (PubMed:17255108). {ECO:0000250|UniProtKB:Q9WVH9, ECO:0000269|PubMed:10428823, ECO:0000269|PubMed:17255108, ECO:0000269|PubMed:18185537}.;
- Disease
- DISEASE: Neuropathy, hereditary, with or without age-related macular degeneration (HNARMD) [MIM:608895]: An autosomal dominant neuropathy of the Charcot-Marie-Tooth disease group, characterized by distal muscle weakness and atrophy variably affecting the lower and upper limbs. Distal sensory impairment and decreased nerve conduction velocities are present in most but not all patients. Additional variable features are age-related macular degeneration, joint hypermobility, and hyperelastic skin. {ECO:0000269|PubMed:21576112, ECO:0000269|PubMed:23328402}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cutis laxa, autosomal dominant, 2 (ADCL2) [MIM:614434]: A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. Additional variable clinical features are gastrointestinal diverticula, hernia, and genital prolapse. Rare manifestations are pulmonary artery stenosis, aortic aneurysm, bronchiectasis, and emphysema. {ECO:0000269|PubMed:12618961}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100]: A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. The clinical spectrum of autosomal recessive cutis laxa is highly heterogeneous with respect to organ involvement and severity. Type I autosomal recessive cutis laxa is a specific, life-threatening disorder with organ involvement, lung atelectasis and emphysema, diverticula of the gastrointestinal and genitourinary systems, and vascular anomalies. Associated cranial anomalies, late closure of the fontanel, joint laxity, hip dislocation, and inguinal hernia have been observed but are uncommon. {ECO:0000269|PubMed:12189163, ECO:0000269|PubMed:16652333, ECO:0000269|PubMed:16691202, ECO:0000269|PubMed:17035250, ECO:0000269|PubMed:18185537, ECO:0000269|PubMed:20007835, ECO:0000269|PubMed:20599547}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations affecting this gene can modify the phenotype of diseases caused by ELN mutations. {ECO:0000269|PubMed:19194475}.; DISEASE: Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:15269314, ECO:0000269|PubMed:16652333, ECO:0000269|PubMed:20007835, ECO:0000269|PubMed:20599547}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.175
Intolerance Scores
- LoFtool
- 0.0398
- RVIS EVS
- -0.58
- RVIS percentile EVS
- 18.59
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.545
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |